LNAS

LNAS_251d32f5c0.png

ETFS Ultra Long Nasdaq 100 Hedge Fund

ASX Code: LNAS
-

ETFS Ultra Long Nasdaq 100 Hedge Fund (ASX Code: LNAS) is a trading product offering positively geared exposure to the Nasdaq-100 Index.


-

About LNAS

LNAS is an exchange traded managed fund that aims to provide investors with geared returns that are positively related to the returns of the Nasdaq-100 Index. LNAS provides exposure to the Nasdaq-100 Index within a target range of 200% to 275% of the LNAS net asset value. Over a short interval of time, this means that for every 1% movement in the Nasdaq-100 Index, an investment in LNAS is anticipated to return between 2.00% and 2.75%, depending on the degree of leverage deployed by the fund manager over that time interval (subject to fees and costs).

Furthermore, LNAS is currency hedged, meaning that the fund manager will aim to reduce, but may not eliminate, exposure to movements in the Australian dollar/U.S. dollar exchange rate.

LNAS is not recommended for investors as a long-term portfolio position.

-

Why consider LNAS

1

A high conviction trading tool for short-term market exposure to the Nasdaq-100 Index.

2

Potential to magnify returns (losses could be magnified, though not beyond the amount invested).

3

Simple to use, avoiding the complexities associated with direct derivative investments, such as CFDs.

-

FAQs

What is the Nasdaq-100 Index?

The Nasdaq-100 Index is one of the world’s preeminent large-cap growth indices, featuring some of the planet’s the most iconic companies. It includes 100 of the largest U.S. domestic and international non-financial companies listed on the Nasdaq Stock Markets based on market capitalisation.

With a market cap of US$15t at the end of 2020, the Nasdaq-100 has a proven history of growth, impact and performance.

The Nasdaq-100 Index is home to some of the world’s most innovative companies—including Apple, Google, Intel and Tesla.

Technology companies account for more than 50% of the index’s weight, but all listed companies are disruptin